Error: Could not add to watchlist. X

Tekla Life Sciences Investors

+ Watchlist
XHQLX:US
NASDAQ GM
17.86
USD
0.49
2.67%
As of 20:00:33 ET on 02/08/2016.
Fund Type
Closed-End Fund
52Wk Range
17.86 - 30.06
1 Yr Return
-22.21%
YTD Return
-26.14%
Open
17.86
Day Range
17.86 - 17.86
Previous Close
18.35
52Wk Range
17.86 - 30.06
1 Yr Return
-22.70%
YTD Return
-26.14%
Fund Type
Closed-End Fund
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
U.S.
NAV (on 02/08/2016)
17.86
Total Assets (m USD) (on 06/26/2015)
562.317
Inception Date
05/08/1992
Last Dividend (on 12/28/2015)
0.71
Dividend Indicated Gross Yield
10.53%
Fund Managers
DANIEL R OMSTEAD "DAN"
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
0.00%
Current Mgmt Fee
1.05%
Expense Ratio
1.32%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 443.12 k 43.51 m 9.40
Celgene Corp 371.52 k 40.19 m 8.68
Incyte Corp 259.92 k 28.68 m 6.20
Biogen Inc 79.51 k 23.20 m 5.01
Regeneron Pharmaceuticals Inc 44.62 k 20.76 m 4.48
Alexion Pharmaceuticals Inc 127.80 k 19.99 m 4.32
Vertex Pharmaceuticals Inc 191.38 k 19.93 m 4.31
Illumina Inc 92.73 k 16.30 m 3.52
Teva Pharmaceutical Industries 287.32 k 16.22 m 3.50
Mylan NV 390.32 k 15.71 m 3.40
Profile
Tekla Life Sciences Investors is a diversified, closed-end management investment company incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests mainly in securities of life sciences companies and primarily in securities of public and private companies that are believed to have significant potential for above-average growth.
ADDRESS
H & Q Investors
2 Liberty Square, 9th Floor
Boston, MA 02109
USA
PHONE
1-617-772-8500